Bronchial Diseases  >>  fluticasone propionate/salmeterol xinafoate inhalation powder  >>  Phase 1
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
fluticasone propionate/salmeterol xinafoate inhalation powder / Generic mfg.
NCT00364442: Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics

Completed
1
12
Europe
fluticasone propionate/salmeterol
GlaxoSmithKline
Asthma
04/05
04/05
NCT02260492: Clinical Efficacy Study of Salmeterol Xinafoate/Fluticasone Propionate in Asthma

Completed
1
879
US
OT329 (combination of fluticasone propionate and salmeterol xinafoate), Advair Diskus (combination of fluticasone propionate and salmeterol xinafoate), Placebo
Oriel Therapeutics
Asthma
05/15
07/15
NCT02218762: A Study in Patients With Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered Via the ROTAHALER® Inhaler Relative to the DISKUS® Inhaler

Withdrawn
1
0
RoW
Fluticasone Propionate/Salmeterol Xinafoate DISKUS, Placebo to Match DISKUS, Fluticasone Propionate/Salmeterol Xinafoate ROTACAPS, Placebo to Match ROTACAPS
GlaxoSmithKline
Asthma
06/15
06/15

Download Options